Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 October 2019 | Story Valentino Ndaba | Photo Barend Nagel
BCom degree
Prospective students are invited to apply for the new BCom Business and Financial Analytics 2020 intake.

A new qualification has recently been added to the University of the Free State (UFS) curriculum and 30 prospective students still have the opportunity to form part of the BCom with specialisation in Business and Financial Analytics intake for 2020. The deadline for applications has been extended to 31 October 2019. 

Committed to the 4th industrial revolution

This flagship degree has been designed for the 4th Industrial Revolution as it integrates quantitative analysis, computer science, statistics and business. This new qualification will equip graduates to become high-functioning executives in the modern global business world. 

“The Faculty of Economic and Management Sciences identified the need for a BCom programme incorporating some of these skills in a more deliberate way, in order to prepare our graduates for a changing job market,” says Lizette Pretorius, Faculty Manager.

On par with global standards

International institutions such as Harvard Business School, Carnegie Mellon University, Duke University, and Columbia University have led the way by adopting this cohesive approach to business studies. These universities form part of a listing of the 25 top US schools offering Master’s in Business Analytics programmes. 

The UFS is following in these leading institutions as part of its Integrated Transformation Plan (ITP) to produce globally competitive graduates. According to the ITP: “The future state of engaged scholarship will be an important anchor in maintaining the relevance of the academic syllabus, and linking real local needs to the global knowledge project.”

 Click here to complete the application form. 

Please email the form and required documents to Lizette Pretorius at LPretorius@ufs.ac.za.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept